FDA NEWS

ProStrakan Receives US FDA Approval for Sancuso - Phramalive.com
GALASHIELS, Scotland, 15 September, 2008 – ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, today announces that it has received approval from the US Food and Drug Administration (FDA) for Sancuso®, ProStrakan
Source: www.pharmalive.com

Invitrogen, Biocare to Market FDA Approved Breast Cancer Test - MSN MoneyCentral
Invitrogen Corporation, IVGN , a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive U.S. distribution agreement with Biocare Medical LLC, a leading provider of immunohistochemistry
Source: news.moneycentral.msn.com

FDA Web Site on Drug Ads Developed by Drug Industry PR Firm - Center for Science in Public Interest
WASHINGTON—Drug ads can be confusing and often deceptive, so it makes sense that the Food and Drug Administration would develop a web site aimed at helping consumers separate fact from fiction. But to develop such a site the FDA turned to a
Source: www.cspinet.org

FDA Expands Use of Cervical Cancer Vaccine - Time
(WASHINGTON) — The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well. The Food and Drug
Source: www.time.com

Hope, confusion in race for ovarian cancer tests - MSNBC
WASHINGTON - Does a test that promises to find ovarian cancer sooner really do so? Could other tests nearing the market prolong survival by getting patients the right care faster? A race is on for blood tests to better detect this intractable killer
Source: www.msnbc.msn.com

Pfizer Safety Site Highlights Reporting of Drug Side Effects to FDA - Wall Street Journal
It looks like Pfizer has followed Consumers Union’s advice in developing a new site about drug safety. In the upper right corner, the site has a link that directs users to the FDA’s MedWatch page for doing just that. It reminded us of a post we
Source: blogs.wsj.com

Bausch & Lomb says FDA approves Akreos lens - Forbes
Eye care products maker Bausch & Lomb said Monday its Akreos implantable lens has received regulatory approval in the U.S., and it plans to begin shipping the product later this month. The Akreos Advanced Optics Aspheric Lens, which is designed to
Source: www.forbes.com

FDA accepts for review the Complete Response to ceftobiprole NDA - Phramalive.com
BASEL, Switzerland, September 15, 2008 - Basilea Pharmaceutica Ltd. announces that the Food and Drug Administration (FDA) has accepted for review the Complete Response to the ceftobiprole New Drug Application (NDA) Approvable Letter. The Complete
Source: www.pharmalive.com